M2I Life Sciences Revenue and Competitors

M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of proprietary DMFs and has already successfully applied its nonconventional retrosynthetic approach of active ingredients, using continuus processing, to solve important quality and stability issues on proprietary APIs. M2I also develops pheromones based solutions for crop protection and veterinary art. M2I works in close partnership with its clients to develop and supply high quality molecules in a cost efficient way.